Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Anti-inflammatory and antioxidant effects of ranolazine on primary cultured astrocytes

  • 320 Accesses

Introduction

Because of its ability to block late INa [1], ranolazine is used as an antianginal agent for the treatment of chronic angina pectoris when angina is not adequately controlled by other agents [2]. Besides its cardiovascular effects, ranolazine improves different neuronal functions, and thus its use has been proposed for the treatment of pain and epileptic disorders [3, 4]. Since astrocytes are involved in neuronal inflammatory processes, and autoimmune and neurodegenerative diseases [5], we have investigated the antiinflammatory and antioxidant effects of ranolazine in primary cultured astrocytes.

Methods

We incubated differentiated rat astrocytes in primary culture (10 days of culture) [5] for 24 hours with ranolazine (10-5, 10-6, 10-7 M). We measured the protein expression levels of PPARy and Cu/Zn-SOD by western blot technique. Protective effect of ranolazine on cell viability was assayed using MTT conversion assay. Finally, to evaluate the effect of ranolazine on the IL-1β cytokine and TNFα mediators, we used the enzyme-linked immunosorbent assay technique.

Results

Compared with control cells, treatment with ranolazine induced an increment of anti-inflammatory PPARy and reduced the proinflammatory mediators IL-1 β and TNFα in primary cultured astrocytes. Ranolazine (10-6 M) also increased the expression of antioxidant protein Cu/Zn-SOD and caused a significant increase in cell viability.

Conclusion

Ranolazine decreases inflammatory mediators IL-1 β and TNFα, and increases anti-inflammatory PPARy as well as the antioxidant Cu/Zn-SOD in astrocytes in culture. These results suggest that ranolazine could be useful as a neuroprotective drug in pathologies inducing inflammatory damage and oxidant processes.

References

  1. 1.

    Belardinelli L, et al.: J Pharmacol Exp Ther. 2013, 344: 23-32. 10.1124/jpet.112.198887

  2. 2.

    Siddiqui MA, et al.: Drugs. 2006, 66: 693-710. 10.2165/00003495-200666050-00010

  3. 3.

    Park YY, et al.: J Neurophysiol. 2013, 109: 1378-1390. 10.1152/jn.00435.2012

  4. 4.

    Ka h, lig KM, et al.: Br J Pharmacol. 2010, 161: 1414-1426. 10.1111/j.1476-5381.2010.00976.x

  5. 5.

    Vallés SL, et al.: Brain Pathol. 2004, 14: 365-371.

Download references

Author information

Correspondence to FB El Amrani.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

El Amrani, F., Guerra, S., Aguirre-Rueda, D. et al. Anti-inflammatory and antioxidant effects of ranolazine on primary cultured astrocytes. Crit Care 18, P447 (2014). https://doi.org/10.1186/cc13637

Download citation

Keywords

  • Neurodegenerative Disease
  • Antioxidant Effect
  • Proinflammatory Mediator
  • Ranolazine
  • Blot Technique